Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.
about
Combined analysis of CRMP4 methylation levels and CAPRA-S score predicts metastasis and outcomes in prostate cancer patients.External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients.Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
P2860
Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Improved decision making in in ...... s after radical prostatectomy.
@en
type
label
Improved decision making in in ...... s after radical prostatectomy.
@en
prefLabel
Improved decision making in in ...... s after radical prostatectomy.
@en
P2093
P2860
P1476
Improved decision making in in ...... es after radical prostatectomy
@en
P2093
Adil Ouzzane
Alexandre de La Taille
Annabelle Goujon
Arnaud Méjean
Bastien Cabarrou
Committee of Cancerology of the Association of French Urology
François Rozet
Guillaume Ploussard
Jérome Gas
Laurent Salomon
P2860
P2888
P304
P356
10.1007/S00345-016-1979-Z
P577
2016-12-16T00:00:00Z
P6179
1031251264